Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 6,382 | 5,213 | 6,024 | 6,983 | 6,383 |
| Operating Income | -6,382 | -5,213 | -6,024 | -6,983 | -6,383 |
| Other Income | 70 | 112 | 141 | 149 | 188 |
| Pre-tax Income | -6,312 | -5,101 | -5,883 | -6,834 | -6,195 |
| Net Income Continuous | -6,312 | -5,101 | -5,883 | -6,834 | -6,195 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 293 |
| Net Income | $-6,312 | $-5,101 | $-5,883 | $-6,834 | $-5,902 |
| EPS Basic Total Ops | 129,673.20 | -6,436.33 | -22,247.48 | -132,449.60 | -67,960.94 |
| EPS Basic Continuous Ops | 129,673.80 | -6,436.41 | -22,247.55 | -132,450.10 | -49,981.81 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -17,946.65 |
| EPS Diluted Total Ops | 129,673.20 | -6,436.33 | -22,247.48 | -132,449.60 | -67,960.94 |
| EPS Diluted Continuous Ops | 129,673.80 | -6,436.41 | -22,247.55 | -132,450.10 | -49,981.81 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -17,946.65 |
| EPS Diluted Before Non-Recurring Items | N/A | -6,255.87 | -21,765.20 | N/A | N/A |
| EBITDA(a) | $-6,311 | $-5,129 | $-5,933 | $-6,877 | $-6,267 |